Login / Signup

An overview on the current status of cancer nanomedicines.

Nasimudeen R JabirKhalid AnwarChelapram K FirozMohammad OvesMohammad Amjad KamalShams Tabrez
Published in: Current medical research and opinion (2018)
In this review, we have summarized cancer nanomedicines (active and passive drug delivery) available in the market. We have also discussed other nanomedicines that are at different stages of clinical trials.
Keyphrases
  • papillary thyroid
  • clinical trial
  • drug delivery
  • current status
  • squamous cell
  • health insurance
  • childhood cancer
  • open label